AMG:ETR
Amgen Inc
€388.50
arrow_downward
-1.11%(-4.35) 1D
Oct 16, 5:35:55 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMG...
Open
€385.95
High
€388.85
Low
€384.70
Mkt. cap
233.82B
Avg. vol.
579.00
Volume
792.00
52-wk high
€388.85
52-wk low
€247.65
No. of employees
32K
Open
€385.95
High
€388.85
Low
€384.70
Mkt. cap
233.82B
Avg. vol.
579.00
Volume
792.00
52-wk high
€388.85
52-wk low
€247.65
No. of employees
32K
News stories
From web sources and news partners
MarketBeat
·
3 hours ago
Amgen Inc. $AMGN Stock Sold by TD Waterhouse Canada Inc.
Barchart.com
·
1 day ago
Amgen's Q3 2026 Earnings: What to Expect
Simply Wall Street
·
1 day ago
Amgen (AMGN) Nears Earnings, Is The Stock Pricey?
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees31.5K
Founded1980
HeadquartersThousand Oaks, California, United States
SectorBiotechnology
Websiteamgen.com